Navigation Links
CyberKnife Cancer Institute of Chicago Is the First to Offer CyberKnife Treatment in the City of Chicago

CHICAGO, Aug. 30, 2012 /PRNewswire/ -- CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital, is the first and only center within the City of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery treatment. The 10,000 sq. ft. state-of-the-art facility is treating patients with cancers of the brain, spine, pancreas, prostate, kidney, liver and lung. The technology is also effective for certain nervous system conditions like trigeminal neuralgia and arteriovenous malformations. The center is supported throughout the Chicagoland area by 24 credentialed physicians as well as a partnership with Radiology Oncology, S.C., a division of Alpha Med Physicians Group.


As a non-invasive alternative to surgery, CyberKnife Robotic Radiosurgery can effectively treat complex tumors located virtually anywhere in the body. These treatments offer a reduced the risk of complications, allow the treatment of recurrent tumors, and are comfortable procedures that can usually be completed in around an hour per treatment.

"We are thrilled to have CyberKnife technology in Chicago and conveniently on Chicago's Magnificent Mile. It grants us the opportunity to treat patients with the most revolutionary tumor technology available for a higher level of patient care and ultimately treatment success," says Dr. Adam Dickler, Medical Director of the CyberKnife Cancer Institute of Chicago.

To learn more about CyberKnife and locate a referring physician, visit

About CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital

CyberKnife Cancer Institute of Chicago is the only center within the city of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery system. The 10,000 sq. ft. state-of-the-art facility is supported by a diverse team of skilled radiation oncologists in partnership with Swedish Covenant Hospital. The CyberKnife Cancer Institute of Chicago is located in downtown Chicago, just steps from the Magnificent Mile and is easily accessible by public transportation and offers free underground parking for patients CyberKnife® is a registered trademark of Accuray Incorporated and is used with permission.

Press contact: Leigh Ginther, or 773-989-1685.

SOURCE CyberKnife Cancer Institute of Chicago
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
2. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
3. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
4. Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Healths TERC Gene Marker
5. Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
6. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
7. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
8. Breast Cancer Diagnostic and Drug Technologies: Global Markets
9. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
10. Brain Cancer Research in Seattle Leads to New Treatment Options for Patients
11. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
Post Your Comments:
(Date:11/24/2015)... , Nueva York , ... Biomedical Devices (ABD), fabricante del Avery Breathing Pacemaker ... Anders Jonzon , MD; Ph.D. como consultor clínico. ...   --> Foto - ... --> El doctor Jonzon es un fisiólogo ...
(Date:11/24/2015)... 24, 2015 --> ... Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, ... Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - ... was valued at $1.90 Billion in 2014 and is expected ... 4.4% during the forecast period of 2015 to 2020. ...
(Date:11/24/2015)... FRAMINGHAM, Mass. , Nov. 24, 2015   ... leading innovator of less-invasive, miniaturized circulatory support technologies that ... announced that President and Chief Executive Officer Doug ... Jaffray 27 th Annual Healthcare Conference on December ... being held December 1-2 in New York ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA ... Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. ... traditional cutting tools, such as the scalpel and high-speed drill, which can both cause ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Charitable giving ... charitable donations are made in the last five weeks of the year totalling over ... created in 2012 to connect the nation’s charities with those individuals who want to ...
(Date:11/24/2015)... (PRWEB) , ... November 25, 2015 , ... ... technologies and development solutions for drugs, biologics, consumer health and global clinical supply ... present at the upcoming Clinical Trial Supply East Asia Conference, to be held ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Preparing for ... p.m. – 3:00 p.m. EST, , FDA has long asserted that ... regulations apply to performing the tests and do not meet the device regulations. , ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... LENR HHT Bolier Reactor System. Brillouin is the developer of renewable energy technologies ... low energy nuclear reactions (“LENR”), announced today that its WET™ and HHT™ Boiler ...
Breaking Medicine News(10 mins):